During the past decade, Maryland Cardiovascular Specialists conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maryland Cardiovascular Specialists" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maryland Cardiovascular Specialists" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "TIMI Study Group" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Maryland Cardiovascular Specialists" are "Obesity" (3 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Myocardial Infarction" (2 trials) and "Overweight" (2 trials). Many other conditions were trialed in "Maryland Cardiovascular Specialists" in a lesser frequency.

Most popular intervention types in "Maryland Cardiovascular Specialists" are "Drug" (21 trials), "Other" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Tirzepatide" (4 trials), "Empagliflozin" (2 trials), "K-877" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Maryland Cardiovascular Specialists" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Maryland Cardiovascular Specialists". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Maryland Cardiovascular Specialists, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Maryland Cardiovascular Specialists, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".